TG Therapeutics (NASDAQ:TGTX) Earnings Information
TG Therapeutics last announced its earnings results on November 9th, 2020. The biopharmaceutical company reported ($0.73) earnings per share for the quarter, missing the consensus estimate of ($0.41) by $0.32. The company earned $0.04 million during the quarter, compared to analysts' expectations of $0.04 million. TG Therapeutics has generated ($1.83) earnings per share over the last year. TG Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 2nd, 2021 based off prior year's report dates.
TG Therapeutics Earnings Estimates and Actuals by Quarter
The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.
TG Therapeutics (NASDAQ:TGTX) Earnings Estimates
Current Year EPS Consensus Estimate: $-2.2 EPS
Next Year EPS Consensus Estimate: $-2 EPS
TG Therapeutics (NASDAQ TGTX) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)